Skip to content

Sector

Health Care sector explained

Companies that develop medicines and vaccines, make medical equipment, or run hospitals and health insurance plans. Much of what they earn is paid by insurers and government programs.

For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

Companies we cover

2 companies in Health Care

  • Eli Lilly discovers, makes and sells medicines, mostly for diabetes and obesity, in about 90 countries, with revenue of $65.2 billion in FY2025.

    Discloses: someUpdated for Q3 FY2026

  • Moderna sells mRNA vaccines, almost all for COVID, with revenue of $1,944 million and a net loss of $2,822 million in FY2025.

    Discloses: someUpdated for Q2 FY2026

How companies in this sector earn

How do Health Care companies make money?

  • Drug makers sell medicines through wholesalers, and insurers and government programs often receive rebates off the list price.
  • Patents stop direct copies for a set time; after that, cheaper generic versions can take much of a drug's sales.
  • Vaccine makers sell to governments and to distributors that supply pharmacies and clinics; demand can shift with seasons and outbreaks.
  • Hospitals are paid for the care they provide, and health insurers collect premiums and pay members' medical bills.
  • Research and development is often among drug makers' largest costs, and most drug candidates fail before approval.

Who regulates it

Food and Drug Administration (FDA), for drugs, vaccines and medical devices · Centers for Medicare & Medicaid Services (CMS), for Medicare and Medicaid coverage, payment and drug price negotiation · Centers for Disease Control and Prevention (CDC), for vaccine recommendations · Federal Trade Commission (FTC), for competition, including drug company mergers · US Patent and Trademark Office (USPTO), for drug patents

What moves results across the sector

  • FDA approvals and safety decisions on new drugs and vaccines.
  • Government rules on drug prices, including Medicare price negotiation, and what insurers agree to cover.
  • Patent expiry dates, after which generic copies can reach the market.
  • Vaccine recommendations from health agencies, which can shift demand for shots.

Words you'll meet

Key terms

Clinical trial
A test of a new drug or vaccine in people, run in stages before a maker seeks approval.
Patent
A legal right that stops others from making and selling the same invention for a set time.
Generic drug
A copy of a brand-name medicine, sold after the original's legal protection ends.
mRNA vaccine
A vaccine that uses messenger RNA to make cells build a harmless virus piece, training the immune system.
Pharmacy benefit manager
A company that negotiates drug rebates and manages drug coverage for insurers and employers.
Medicare and Medicaid
Government health programs: Medicare mainly covers older people, and Medicaid covers many people with low incomes.

Last updated Nov 1, 2026.

Disclaimer

For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a registered investment adviser or other qualified professional.

Cityfort, its owners and contributors may or may not hold securities of companies covered. Cityfort is not paid by any company it covers. Content is not an offer or solicitation to buy or sell any security, including in any initial public offering.

Read the positions policy
Read the full disclaimer

Cityfort publishes general educational content that explains how listed companies work. Cityfort is not registered with the US Securities and Exchange Commission or any state securities regulator as an investment adviser, and is not a broker-dealer or a member of FINRA. Cityfort does not provide investment, tax or legal advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security. Nothing on the site is tailored to any person's circumstances.

All information is taken from publicly available sources, mainly company filings with the SEC, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.

Statements by company management, including forward-looking statements and guidance, are reported as the company's statements, with their date and source; they are not our forecasts. Adjusted (non-GAAP) figures are the company's own measures and are shown next to the official (GAAP) figures.